Cargando…

Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features

BACKGROUND: To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate cancer (PCa). METHODS: We performed a prospective 3 T MRI study comparing the...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra, Adalgisa, Alves, Filipe Caseiro, Maes, Kris, Joniau, Steven, Cassis, João, Maio, Rui, Cravo, Marília, Mouriño, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784252/
https://www.ncbi.nlm.nih.gov/pubmed/36550525
http://dx.doi.org/10.1186/s40644-022-00509-8
_version_ 1784857766175703040
author Guerra, Adalgisa
Alves, Filipe Caseiro
Maes, Kris
Joniau, Steven
Cassis, João
Maio, Rui
Cravo, Marília
Mouriño, Helena
author_facet Guerra, Adalgisa
Alves, Filipe Caseiro
Maes, Kris
Joniau, Steven
Cassis, João
Maio, Rui
Cravo, Marília
Mouriño, Helena
author_sort Guerra, Adalgisa
collection PubMed
description BACKGROUND: To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate cancer (PCa). METHODS: We performed a prospective 3 T MRI study comparing the clinical and MRI data on pECE obtained from patients treated using robotic-assisted radical prostatectomy (RARP) at our institution. The covariates under consideration were prostate-specific antigen (PSA) levels, the patient’s age, prostate volume, and MRI interpretative features for predicting pECE based on the Prostate Imaging–Reporting and Data System (PI-RADS) version 2.0 (v2), as well as tumor capsular contact length (TCCL), length of the index lesion, and prostate biopsy Gleason score (GS). Univariable and multivariable logistic regression models were applied to explore the statistical associations and construct the model. We also recruited an additional set of participants—which included 59 patients from external institutions—to validate the model. RESULTS: The study participants included 184 patients who had undergone RARP at our institution, 26% of whom were pECE+ (i.e., pECE positive). Significant predictors of pECE+ were TCCL, capsular disruption, measurable ECE on MRI, and a GS of ≥7(4 + 3) on a prostate biopsy. The strongest predictor of pECE+ is measurable ECE on MRI, and in its absence, a combination of TCCL and prostate biopsy GS was significantly effective for detecting the patient’s risk of being pECE+. Our predictive model showed a satisfactory performance at distinguishing between patients with pECE+ and patients with pECE−, with an area under the ROC curve (AUC) of 0.90 (86.0–95.8%), high sensitivity (86%), and moderate specificity (70%). CONCLUSIONS: Our predictive model, based on consistent MRI features (i.e., measurable ECE and TCCL) and a prostate biopsy GS, has satisfactory performance and sufficiently high sensitivity for predicting pECE+. Hence, the model could be a valuable tool for surgeons planning preoperative nerve sparing, as it would reduce positive surgical margins.
format Online
Article
Text
id pubmed-9784252
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97842522022-12-24 Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features Guerra, Adalgisa Alves, Filipe Caseiro Maes, Kris Joniau, Steven Cassis, João Maio, Rui Cravo, Marília Mouriño, Helena Cancer Imaging Research Article BACKGROUND: To construct a model based on magnetic resonance imaging (MRI) features and histological and clinical variables for the prediction of pathology-detected extracapsular extension (pECE) in patients with prostate cancer (PCa). METHODS: We performed a prospective 3 T MRI study comparing the clinical and MRI data on pECE obtained from patients treated using robotic-assisted radical prostatectomy (RARP) at our institution. The covariates under consideration were prostate-specific antigen (PSA) levels, the patient’s age, prostate volume, and MRI interpretative features for predicting pECE based on the Prostate Imaging–Reporting and Data System (PI-RADS) version 2.0 (v2), as well as tumor capsular contact length (TCCL), length of the index lesion, and prostate biopsy Gleason score (GS). Univariable and multivariable logistic regression models were applied to explore the statistical associations and construct the model. We also recruited an additional set of participants—which included 59 patients from external institutions—to validate the model. RESULTS: The study participants included 184 patients who had undergone RARP at our institution, 26% of whom were pECE+ (i.e., pECE positive). Significant predictors of pECE+ were TCCL, capsular disruption, measurable ECE on MRI, and a GS of ≥7(4 + 3) on a prostate biopsy. The strongest predictor of pECE+ is measurable ECE on MRI, and in its absence, a combination of TCCL and prostate biopsy GS was significantly effective for detecting the patient’s risk of being pECE+. Our predictive model showed a satisfactory performance at distinguishing between patients with pECE+ and patients with pECE−, with an area under the ROC curve (AUC) of 0.90 (86.0–95.8%), high sensitivity (86%), and moderate specificity (70%). CONCLUSIONS: Our predictive model, based on consistent MRI features (i.e., measurable ECE and TCCL) and a prostate biopsy GS, has satisfactory performance and sufficiently high sensitivity for predicting pECE+. Hence, the model could be a valuable tool for surgeons planning preoperative nerve sparing, as it would reduce positive surgical margins. BioMed Central 2022-12-23 /pmc/articles/PMC9784252/ /pubmed/36550525 http://dx.doi.org/10.1186/s40644-022-00509-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Guerra, Adalgisa
Alves, Filipe Caseiro
Maes, Kris
Joniau, Steven
Cassis, João
Maio, Rui
Cravo, Marília
Mouriño, Helena
Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
title Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
title_full Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
title_fullStr Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
title_full_unstemmed Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
title_short Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features
title_sort early biomarkers of extracapsular extension of prostate cancer using mri-derived semantic features
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784252/
https://www.ncbi.nlm.nih.gov/pubmed/36550525
http://dx.doi.org/10.1186/s40644-022-00509-8
work_keys_str_mv AT guerraadalgisa earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT alvesfilipecaseiro earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT maeskris earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT joniausteven earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT cassisjoao earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT maiorui earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT cravomarilia earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures
AT mourinohelena earlybiomarkersofextracapsularextensionofprostatecancerusingmriderivedsemanticfeatures